As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the FDA has issued a final guidance regarding pharmacogenomic data submissions.
Name *
E-mail *
Web site
Comment
Discussion
No comments for “FDA guidelines to help personalized drug development”
Post a comment